Announce Date | 05/15/2025 |
EPS Normalized Actual | $6.64 (Beat by $1.08) |
EPS GAAP Actual | $6.64 (Beat by $1.08) |
Revenue Actual | $12.525B |
Revenue Surprise | Beat by $12525M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2028 | 44.0764 | 11.53 | 41.20061 | 47.14705 | 5 |
Oct 2028 | 37.7401 | 13.46 | 35.85216 | 40.5701 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 6.6544 | 6.6544 | 12.525B | -21.64% | 12525M |
FQ1 2025 (Jan 2025) | 3.2 | 3.2 | 6.809B | -78.95% | 6809M |
FQ4 2024 (Oct 2024) | 0 | 0 | 10.827B | -40% | 10827M |
FQ3 2024 (Jul 2024) | 6.29 | 6.29 | 13.152B | 100% | 13152M |
FQ2 2024 (Apr 2024) | 8.56 | 8.56 | 15.235B | -14.13% | 15235M |
FQ1 2024 (Jan 2024) | 6.23 | 6.23 | 12.185B | -3.83% | 12185M |
FQ4 2023 (Oct 2023) | 8.3 | 8.3 | 15.158B | 100% | 15158M |
FQ2 2023 (Apr 2023) | 9.69 | 9.69 | 17.387B | 23.1% | 17387M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 7.01079 | -- | 6.60043 | 7.51147 | 7 |
FQ3 2027 (Jul 2027) | 6.89133 | -- | 6.48796 | 7.38348 | 9 |
FQ2 2027 (Apr 2027) | 6.69608 | -- | 6.30414 | 7.17428 | 15 |
FQ1 2027 (Jan 2027) | 3.82952 | -- | 3.60537 | 4.10301 | 7 |
FQ4 2026 (Oct 2026) | 7.24812 | -- | 6.96786 | 7.69189 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 11.72B | -- | 11.2B | 12.37B | 5 |
FQ3 2027 (Jul 2027) | 11.41B | -- | 10.9B | 12.04B | 5 |
FQ2 2027 (Apr 2027) | 11.49B | -- | 10.97B | 12.12B | 10 |
FQ1 2027 (Jan 2027) | 7.73B | -- | 7.38B | 8.16B | 7 |
FQ4 2026 (Oct 2026) | 13.22B | -- | 12.83B | 13.84B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 6.6544 | 6.6544 | 100% | |
FQ1 2025 (Jan 2025) | 3.2 | 3.2 | 100% | |
FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Jul 2024) | 6.29 | 6.29 | 100% | |
FQ2 2024 (Apr 2024) | 8.56 | 8.56 | 100% | |
FQ1 2024 (Jan 2024) | 6.23 | 6.23 | 100% | |
FQ4 2023 (Oct 2023) | 8.3 | 8.3 | 100% | |
FQ2 2023 (Apr 2023) | 9.69 | 9.69 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $12.53B | $12525M | 100% |
FQ1 2025 (Jan 2025) | $0B | $6.81B | $6809M | 100% |
FQ4 2024 (Oct 2024) | $0B | $10.83B | $10827M | 100% |
FQ3 2024 (Jul 2024) | $0B | $13.15B | $13152M | 100% |
FQ2 2024 (Apr 2024) | $0B | $15.24B | $15235M | 100% |
FQ1 2024 (Jan 2024) | $0B | $12.19B | $12185M | 100% |
FQ4 2023 (Oct 2023) | $0B | $15.16B | $15158M | 100% |
FQ2 2023 (Apr 2023) | $0B | $17.39B | $17387M | 100% |